Bastida G, Nos P, Aguas M, Beltran B, Rubin A, Dasi F, Ponce J (2005): Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 22, 775–782. https://doi.org/10.1111/j.1365-2036.2005.02636.x Cheng K, Benten D, Bhargava K, Inada M, Joseph B, Palestro C, Gupta S (2009): Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice. Hepatology 50, 1194–1203. https://doi.org/10.1002/hep.23120 Costa O, Fournel C, Lotchouang E, Monier JC, Fontaine M (1984): Specificities of antinuclear antibodies detected in dogs with systemic lupus erythematosus. Veterinary Immunology and Immunopathology 7, 369–382. https://doi.org/10.1016/0165-2427(84)90094-1 Ettinger SJ, Feldman EC (2005): Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat. 6th edn. Elsevier Saunders, St. Louis, Mo. Fournel C, Chabanne L, Caux C, Faure JR, Rigal D, Magnol JP, Monier JC (1992): Canine systemic lupus erythematosus. I: A study of 75 cases. Lupus 1, 133–139. https://doi.org/10.1177/096120339200100303 Gisbert JP, Luna M, Gonzalez-Lama Y, Pousa ID, Velasco M, Moreno-Otero R, Mate J (2007): Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Inflammatory Bowel Diseases 13, 1106–1114. https://doi.org/10.1002/ibd.20160 Jones DR (1993): Canine systemic lupus erythematosus: new insights and their implications. Journal of Comparative Pathology 108, 215–228. https://doi.org/10.1016/S0021-9975(08)80286-1 Kim SJ, Park KC, Lee JU, Kim KJ, Kim DG (2011): Therapeutic potential of adipose tissue-derived stem cells for liver failure according to the transplantation routes. Journal of the Korean Surgical Society 81, 176–186. https://doi.org/10.4174/jkss.2011.81.3.176 Ko M, Lee KY, Kim SH, Kim M, Choi JH, Im W, Chung JY (2018): Flow cytometric immunophenotyping of canine adipose-derived mesenchymal stem cells (ADMSCs) and feline ADMSCs using anti-human antibodies. Korean Journal of Veterinary Research 58, 33–37. Mokbel A, El-Tookhy O, Shamaa AA, Sabry D, Rashed L, Mostafa A (2011): Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs. Clinical and Experimental Rheumatology 29, 275–284. Phillips CD, Wongsaisri P, Htut T, Grossman T (2017): Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus. Clinical and Translational Medicine 6. doi: 10.1186/s40169-017-0161-6.  https://doi.org/10.1186/s40169-017-0161-6 Quintanilha LF, Takami T, Hirose Y, Fujisawa K, Murata Y, Yamamoto N, Goldenberg RC, Terai S, Sakaida I (2014): Canine mesenchymal stem cells show antioxidant properties against thioacetamide-induced liver injury in vitro and in vivo. Hepatology Research 44, E206–E217. Stewart MC, Stewart AA (2011): Mesenchymal stem cells: characteristics, sources, and mechanisms of action. Veterinary Clinics of North America: Equine Practice 27, 243–261. Trzil JE, Masseau I, Webb TL, Chang CH, Dodam JR, Liu H, Quimby JM, Dow SW, Reinero CR (2016): Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: A pilot study. Journal of Feline Medicine and Surgery 18, 981–990. https://doi.org/10.1177/1098612X15604351 Villatoro AJ, Fernandez V, Claros S, Rico-Llanos GA, Becerra J, Andrades JA (2015): Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model. Biomed Research International, 2015. doi: 10.1155/2015/527926. https://doi.org/10.1155/2015/527926 Wallisch K, Trepanier LA (2015): Incidence, timing, and risk factors of azathioprine hepatotoxicosis in dogs. Journal of Veterinary Internal Medicine 29, 513–518. https://doi.org/10.1111/jvim.12543